Beta Glucan 500 and Biological Age and Immune Age

Launched by OVATIONLAB · Aug 1, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at whether taking a supplement called Beta Glucan 500 can help slow down or improve signs of aging in healthy adults. Specifically, the study will measure changes in biological age (how old your body appears at a cellular level) and immune age (how well your immune system is working) using special tests before and after 12 weeks of taking the supplement daily.

Adults aged 40 and older who speak English and have recently completed a specific aging test (called TruAge) may be eligible to join, as long as they don’t have certain health conditions like autoimmune diseases, allergies to beta glucan or mushrooms, or chronic illnesses that might make participation unsafe. Pregnant or breastfeeding women are also not eligible. If accepted, participants will take two capsules of Beta Glucan 500 each day for three months, and researchers will compare their biological and immune age markers from before and after the study to see if the supplement made a difference. This study is not yet recruiting but aims to better understand how this supplement might support healthy aging.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adult females or males age ≥ 40 years
• • 2. Ability to read and speak English
• • 3. Previous completion of a TruDiagnostic TruAge test within the past three months to enable comparison of previous biomarkers to the same biomarkers after intervention
• • 4. DunedinPACE estimate of aging \>0.9
• Exclusion Criteria:
• • 1. Current diagnosis and treatment for an autoimmune condition
• • 2. Current use of beta-glucan or mushroom dietary supplement
• • 3. Known allergies to beta glucan, yeast, or mushrooms
• • 4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
• • 5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
• • 6. Participants unable to provide consent